Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (QUADRACEL) | SANOFI PASTEUR | 4 | U8209CB | IM / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Z008587 | IM / LL |
Patient was seen for her 4 year well check on 09/10/2025 and was given her 4-year vaccines that included the MMRV. Mother contacted the office on 09/29/2025 stating that patient had developed a nickel size rash around the injection site. Advised to apply hydrocortisone cream to are to help with the reaction and to contact the office with any other changes or concerns. On October 5th patient started with fever and rash. Patient took her to the Emergency room where they determined that patient had vaccine-induced chicken pox from the MMRV vaccine. Patient was discharged home with Acyclovir. On October 7th patient started with fever again and rapid spreading of rash and parents returned to the Emergency Room where she was admitted until the rash was no longer spreading and the fever was resolved. Patient was discharged on 10/13/2025.
Patient has a diagnoses of B-cell acute Lymphoblastic Leukemia.
B-cell acute Lymphoblastic Leukemia
Patient with diagnosis of Precursor B-cell acute Leukemia and is being treated for that diagnosis.
Penicillin
Positive viral cx for Varicella in the hospital.